Pharmacological manipulation of early PrPres accumulation in the spleen of scrapie-infected mice

  • V. Beringue
  • F. Lamoury
  • K. T. Adjou
  • T. Maignien
  • M. Demoy
  • P. Couvreur
  • D. Dormont
Part of the Archives of Virology. Supplementa book series (ARCHIVES SUPPL, volume 16)


In most experimental models of scrapie and in some naturally infected species, the lymphoreticular system and the spleen in particular play a major role in the pathogenesis of the disease. Previous studies demonstrated scrapie infectivity in peripheral organs from the day of infection up to the terminal stage. The discovery of the abnormal prion protein, PrPres, as a specific molecular hallmark of scrapie should permit enhanced study of scrapie pathogenesis and has some pharmacological applications. In this study, PrPres accumulation was followed day by day in peripheral organs. Four different phases were identified: the circulation of scrapie inoculum, a clearance phase, the peripheral accumulation of PrPres and a plateau phase. This kinetics was then pharmacologically modified (i) by applying the macrophage “suicide” technique to unveil the cellular types involved in scrapie pathogenesis and (ii) with anti-scrapie drugs such as polyene antibiotics, polyanions and Congo red to investigate their mode and site of action.


SCID Mouse Bovine Spongiform Encephalopathy Pharmacological Manipulation Scrapie Agent Polyene Antibiotic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adjou KT, Deslys JP, Pemaimay R, Seman M, Dormont D (1998) Prospects for the pharmacological treatment of human prion diseases. CNS Drugs 10: 83–89CrossRefGoogle Scholar
  2. 2.
    Aguzzi A (2000) Prion diseases, blood and the immune system: concerns and reality. Haematologica 85: 3–10PubMedGoogle Scholar
  3. 3.
    Beringue V, Demaimay R, Adjou KT, Demart S, Lamoury F, Seman M, Lasmézas CI, Deslys JP, Dormont D (1998) Polyene antibiotics in experimental transmissible subacute spongiform encephalopathies, In: Morrison DRO (ed) Prions and brain diseases in animals and humans. Plenum Press, New York, pp 177–185Google Scholar
  4. 4.
    Beringue V, Lasmézas CI, Adjou KT, Demaimay R, Lamoury F, Deslys JP, Seman M, Dormont D (1999) Inhibiting scrapie neuroinvasion by polyene antibiotic treatment of SCID mice. J Gen Virol 80: 1873–1877PubMedGoogle Scholar
  5. 5.
    Beringue V, Demoy M, Lasmézas CI, Gouritin B, Weingarten C, Deslys JP, Andreux JP, Couvreur P, Dormont D (2000) Role of spleen macrophages in the clearance of scrapie agent early in the pathogenesis. J Pathol 190: 495–502PubMedCrossRefGoogle Scholar
  6. 6.
    Beringue V, Adjou KT, Lamoury F, Maignien T, Deslys JP, Race R, Dormont D (2000) Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209 and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent. J Virol 74: 5432–5440PubMedCrossRefGoogle Scholar
  7. 7.
    Brown KL, Stewart K, Ritchie DL, Mabbott NA, Williams A, Fraser H, Morrison WI, Bruce ME (1999) Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nature Med 5: 1308–1312PubMedCrossRefGoogle Scholar
  8. 8.
    Carp RI, Callahan SM (1982) Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17: 201–207PubMedCrossRefGoogle Scholar
  9. 9.
    Caspi S, Halimi M, Yanai A, BenSasson S, Taraboulos A, Gabizon R (1998) The anti-prion activity of Congo red. Putative mechanism. J Biol Chem 273: 3484–3489PubMedCrossRefGoogle Scholar
  10. 10.
    Caughey B, Race RE (1992) Potent inhibition of scrapie-associated PrP accumulation by Congo Red. J Neurochem 59: 768–771PubMedCrossRefGoogle Scholar
  11. 11.
    Caughey B, Brown K, Raymond GJ, Katenstein GE, Thresher W (1994) Binding of thp protease-sensitive form of prion protein PrP to sulfated glycosaminoglycan and Congo red. J Virol 68: 2135–2141PubMedGoogle Scholar
  12. 12.
    Claassen I, Van Rooijen N, Claaseen E (1990) A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage “suicide” technique. J Immunol Methods 134: 153–161PubMedCrossRefGoogle Scholar
  13. 13.
    Collinge J (1999) Variant Creutzfeldt-Jakob disease. Lancet 354: 317–323PubMedCrossRefGoogle Scholar
  14. 14.
    Demaimay R, Adjou KT, Beringue V, Demart S, Lasmézas CI, Deslys JP, Seman M, Dormont D (1997) Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J Virol 71: 9685–9689PubMedGoogle Scholar
  15. 15.
    Demaimay R, Race R, Chesebro B (1999) Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons. J Virol 73: 3511–3513PubMedGoogle Scholar
  16. 16.
    Ingrosso L, Ladogana A, Pocchiari M (1995) Congo red prolongs the incubation period in scrapie-infected hamsters. J Virol 69: 506–508PubMedGoogle Scholar
  17. 17.
    Kimberlin RH, Walker CA (1988) Pathogenesis of experimental scrapie. Ciba Found Symposium 135: 37–62Google Scholar
  18. 18.
    Lasmézas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, Fournier JG, Hauw JJ, Rossier J, Dormont D (1997) Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275: 402–405PubMedCrossRefGoogle Scholar
  19. 19.
    Mabbott NA, Farquhar CF, Brown KL, Bruce ME (1998) Involvement of the immune system in TSE pathogenesis. Immunol Today 19: 201–203PubMedCrossRefGoogle Scholar
  20. 20.
    Maignien T, Lasmézas CI, Beringue V, Dormont D, Deslys JP (1999) Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents. J Gen Virol 80: 3035–3042PubMedGoogle Scholar
  21. 21.
    Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144PubMedCrossRefGoogle Scholar
  22. 22.
    Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349–358PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • V. Beringue
    • 1
  • F. Lamoury
    • 1
  • K. T. Adjou
    • 1
  • T. Maignien
    • 1
  • M. Demoy
    • 2
  • P. Couvreur
    • 2
  • D. Dormont
    • 1
  1. 1.CEA, Service de Neurovirologie, DRM/DSV, CRSSAFontenay aux RosesFrance
  2. 2.Laboratoire de Physico-chimie, Pharmacotechnie et BiopharmacieUniversité Paris XIChatenay-MalabryFrance

Personalised recommendations